Hypertension Diagnostics™ designs, develops, manufactures, and markets proprietary noninvasive medical devices that detect subtle changes in the elasticity of arteries.
It offers CVProfilor DO-2020 and the HD/PulseWave CR-2000 research cardiovascular profiling system.
The company’s products collect 30 seconds of blood pressure waveform data, perform an analysis of the digitized blood pressure waveforms, and generate a CVProfile report that contains information on blood pressure, heart rate, pulse pressure, body surface area, body mass index, and both C1-large and C2-small artery elasticity indices.
It sells its products to primary care physicians, cardiologists, health care professionals, trained medical personnel, research investigators at academic medical research centers, government institutes, cardiovascular specialists, and pharmaceutical firms.
The company markets its products through a representative organization in the United States. Hypertension Diagnostics™ was founded in 1988 and is headquartered in Minneapolis, Minnesota.